OGN

13.9100.00%
RA

Rachel A. Stahler

Executive VP, Chief Information Officer and Chief Digital & Growth Officer

Ms. Rachel A. Stahler serves Chief Digital & Growth Officer since 2025 and is Executive Vice President at Organon & Co. and is Chief Information Officer. She was Chief Digital & Commercial Innovation Officer of Organon & Co. from 2025 to 2025. Ms. Stahler was Chief Information Officer of Organon & Co. from June 02, 2021. Ms. Stahler was Executive VP & Chief Information Officer of Organon & Co. until 2025. She served as an Independent Director at NeoGenomics, Inc. since May 2020 until June 26, 2023. She served as Director at NeoGenomics Laboratories, Inc since 2021 until 2023. She had been Chief Information Officer at Organon & Co. since June 2, 2021 until 2025 and was its Executive Vice President. In her role. Ms. Stahler is driving digital capabilities across all aspects of Organon’s strategy to build value for the company’s offerings and customers. Ms. Stahler joins Organon with two decades of global technology experience in the healthcare industry and a passion for bringing new medicines and solutions to patients in need. She was the Chief Information Officer at inVentiv Group Holdings, Inc. and inVentiv Health Inc. from 2014 to 2017. Ms. Stahler had been Chief Information and Digital Officer of Syneos Health, Inc. (formerly, INC Research Holdings, Inc.) since 2017 until February 2019 and served as its Chief Information Officer since August 3, 2017 until December 2018. Most recently, from 2019 to 2020. Ms. Stahler served as CIO at Allergan plc, a global pharmaceutical company. Ms. Stahler has global technology experience in the pharmaceutical industry. She was responsible for the Division's technology portfolio including the systems supporting study start up, investigator identification and trial monitoring and documentation at inVentiv Health. She served as the Chief Information Officer of Optimer Pharmaceuticals, Inc. from August 2011 to March 2014 and served as its Senior Vice President of Marketing. She spent 8 years at Pfizer, Inc. where she in senior level roles in the pharmaceutical and diversified businesses, including technology lead for a Global Center of Excellence for a significant business unit and global technology leadership positions for multiple therapeutic areas, sales, marketing, market access and strategy. She served as Pfizer’s technology lead for North America Specialty Care and Market Access / Global Strategy, as well as a division of worldwide marketing covering key therapeutic areas such as Urology, Ophthalmology, Pain/Inflammation and EMEA Marketing. She held various roles at Pfizer, Inc. from November 2003 to August 2011. Prior to serving at Pfizer, she served as the Global Vice President of Channel & Market Strategy for SPL WorldGroup, Inc. where she directed market and geographic entry strategies to determine business direction. She helped launch a consulting company in New York City focused on Siebel and CRM process reengineering. Her career began at PriceWaterhouseCoopers, where she was an IT Consultant. Ms. Stahler has a Master of Business Administration from Columbia Business School, where she graduated with highest honors and a Bachelor of Arts in Economics from the University of Pennsylvania, where she graduated summa cum laude.

公司職務